SK bioscience Co.,Ltd. (302440.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
| Market Cap | 3.77T |
| Enterprise Value | 4.13T |
| P/E Ratio | -32.09 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 4.54 |
| Price/Book Ratio | 2.05 |
| Enterprise/Revenue | 5.13 |
| Enterprise/EBITDA | -24.2 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.13 |
| Operating Margin | -0.22 |
| Return On Assets | -0.03 |
| Return On Equity | -0.05 |
| Revenue | 651.37B |
| Revenue/Share | 7,725.68 |
| Gross Profit | 59.49B |
| EBITDA | -60.31B |
| Net Income | -56.17B |
| Diluted EPS | -718.26 |
| Total Cash | 832.6B |
| Total Cash/Share | 9,309.58 |
| Total Debt | 543.37B |
| Total Debt/Equity | 0.31 |
| Current Ratio | 3.6 |
| Book Value Per Share | 22,439.62 |
| 52-Week Change | -26.7 |
| 52-Week High | 56,500 |
| 52-Week Low | 31,500 |
| Moving Average 50 Days | 36,108 |
| Moving Average 200 Days | 40,194.25 |
| Average Volume | 87,870 |
| Shares Outstanding | 78.46M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |